EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8 + T cell dysfunction in lung adenocarcinoma

Xuyu Gu, Junjie Zhu, Tao Ge, Keyi Chen, Yang Yang, Kaiqi Jin, Xinnan Xu

Journal for ImmunoTherapy of Cancer · 2026-10 · 14 (10) · e015190

DOI: 10.1136/jitc-2026-015190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 30.10.2026. Verfasst von Xuyu Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Science Foundation for Distinguished Young Scholars of China, National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aberrant glycolysis and lactate accumulation are hallmarks of solid tumors, yet how tumor-derived lactate contributes to tumor progression has not been fully defined. This study intends to examine the role of glycolysis in lung adenocarcinoma (LUAD) growth and immunosuppression, and to explore the underpinning mechanisms.

Methods

Syngeneic Lewis lung carcinoma models and autochthonous Kras LSL-G12D LUAD mice were used. Glycolysis was inhibited by 2-DG or LDH knockdown, followed by tumor growth and immune-cell composition assessments. Therapeutic anti-IL-35 blockade and CD8+ T depletion were performed using neutralizing antibodies. Chitinase 3-like 1 (CHI3L1) expression, regulatory B cell (Breg) polarization, and B-cell-mediated T-cell suppression were assessed by flow cytometry, RNA sequencing, qPCR, ELISA, immunohistochemistry, and co-culture assays. CUT&Tag, chromatin immunoprecipitation, co-immunoprecipitation, and cell-free transferase assays were used to define the lactylation mechanism.

Results

Glycolysis restriction suppressed tumor growth and metastatic colonization, reduced CD1d hiCD5+IL-35+ Bregs, and restored GZMB+CD8+ T cells. CHI3L1 was markedly downregulated after glycolysis inhibition, whereas recombinant CHI3L1 restored IL-13Rα2+ Breg polarization and impaired CD8+ T-cell responses through STAT3 activation. Lactate increased H3K9 lactylation and CHI3L1 expression, while glycolysis inhibition reduced H3K9la enrichment at the Chi3l1 promoter. HBO1 directly catalyzed H3K9 lactylation and promoted CHI3L1 production. Genetic or pharmacological HBO1 blockade reduced Bregs, enhanced cytotoxic T-cell activity, and improved the efficacy of anti-PD-1 therapy.

Conclusions

This study demonstrates the participation of an HBO1-H3K9la-CHI3L1–IL-13Rα2-STAT3 axis in tumor glycolysis-established Breg polarization and CD8 + T dysfunction. Targeting HBO1 may provide a strategy to enhance the efficacy of PD-1 blockade in LUAD.

Schlagwörter

Stichwörter der Autor:innen

AdenocarcinomaImmune Checkpoint InhibitorImmunotherapyLung Cancer

Autor:innen und Institutionen

  • Department of Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.
  • Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.
  • Department of Thoracic Surgery, Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China kaiqijin@tongji.edu.cn timyangsh@tongji.edu.cn xxn@tongji.edu.cn.
  • Innovation and Incubation Center (IIC), Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai, China.

Förderung

  • National Science Foundation for Distinguished Young Scholars of China
  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Foundation of National Facility for Translational Medicine
  • Youth Found of the National Natural Science Foundation of China
  • National Science Foundation of China
  • Program of Shanghai Academic Research Leader

Zitieren

APA

Gu, X., Zhu, J., Ge, T., Chen, K., Yang, Y., Jin, K., & Xu, X. (2026). Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8 + T cell dysfunction in lung adenocarcinoma. Journal for ImmunoTherapy of Cancer, 14(10), e015190. https://doi.org/10.1136/jitc-2026-015190

Vancouver

Gu X, Zhu J, Ge T, Chen K, Yang Y, Jin K, et al. Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8 + T cell dysfunction in lung adenocarcinoma. Journal for ImmunoTherapy of Cancer. 2026;14(10):e015190. doi:10.1136/jitc-2026-015190

BibTeX
@article{Gu2026,
  author = {Gu, Xuyu and Zhu, Junjie and Ge, Tao and Chen, Keyi and Yang, Yang and Jin, Kaiqi and Xu, Xinnan},
  title = {Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8 + T cell dysfunction in lung adenocarcinoma},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {10},
  pages = {e015190},
  doi = {10.1136/jitc-2026-015190}
}
Kostenlos starten →